Masimo | MASI - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 42M 2M 2025-12
Accuray USD 2.88M 72K 2024-12
Align Technology USD 2M 660K 2023-03
AngioDynamics USD 102K 2K 2025-09
Artivion USD 5.53M 589K 2025-12
AtriCure USD 1.33M 17K 2025-09
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 3M 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
General Electric Aerospace USD 496M 271M 2025-12
Globus Medical USD 17K 5.1B 2025-12
Haemonetics USD 7.21M 3.14M 2025-09
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 19.35B 811.4M 2025-09
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Orthofix International 4.68M 731K 2025-09
Owens Minor USD 27.93M 1.1M 2025-12
ResMed USD 8.79M 14.55M 2025-09
Steris USD 14.9M 0 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Thermo Fisher Scientific USD 365M 18M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12